Evidence map›Paper›PMID 33168598›Full record

ReviewJournal of immunology (Baltimore, Md. : 1950)2020

Regulatory T Cells in Angiogenesis.

Zala Lužnik, Sonia Anchouche, Reza Dana, Jia Yin

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Journal of immunology (Baltimore, Md. : 1950), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07642297 (The Potential Pharmacological Role of the TNF-Like Ligand 1A), which is not on this map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07642297 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

The Potential Pharmacological Role of the TNF-Like Ligand 1A (TL1A) Inhibition in Modulating Systemic Sclerosis (SSc)-Related Skin Fibrosis and Immunological Alterations: A Proof-of-Concept, In Vitro, Study

TypeobservationalSponsorFondazione Policlinico Universitario Campus Bio-MedicoRan2026 to 2028Enrolled20ConditionsSystemic Sclerosis (SSc), Diffuse Cutaneous Systemic Sclerosis, Skin FibrosisArmsTL1A stimulation and inhibition (in vitro)
3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 77 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. AREGMolecular medicine (Cambridge, Mass.) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 3 countries.

Zala LužnikDepartment of Ophthalmology, Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Boston, MA 02114.ORCID 0000-0002-3164-1586
Sonia AnchoucheDepartment of Ophthalmology, Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Boston, MA 02114.
Reza DanaDepartment of Ophthalmology, Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Boston, MA 02114; reza_dana@meei.harvard.edu jia_yin@meei.harvard.edu.ORCID 0000-0002-5732-5100
Jia YinDepartment of Ophthalmology, Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Boston, MA 02114; reza_dana@meei.harvard.edu jia_yin@meei.harvard.edu.ORCID 0000-0003-1340-6758
Massachusetts Eye and Ear Infirmary · US

Funding

MECHANISMS OF SENSITIZATION IN HIGH-RISK CORNEAL GRAFTSR01EY012963 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI DANA, REZA · 2000 to 2025
$15.1M
Mass Eye and Ear-Vision Clinical Scientist Development ProgramK12EY016335 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI Reza Dana · 2004 to 2026
$12.3M
Mechanisms of Neuroregulation of Corneal AngiogenesisK08EY031340 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI YIN, JIA · 2020 to 2022
$756k
NEI NIH HHS K08 EY031340NEI NIH HHS K12 EY016335NEI NIH HHS R01 EY012963
6 · The paper itself

Abstract

Regulatory T cells (Tregs) are crucial mediators of immune homeostasis. They regulate immune response by suppressing inflammation and promoting self-tolerance. In addition to their immunoregulatory role, a growing body of evidence highlights the dynamic role of Tregs in angiogenesis, the process of forming new blood vessels. Although angiogenesis is critically important for normal tissue regeneration, it is also a hallmark of pathological processes, including malignancy and chronic inflammation. Interestingly, the role of Tregs in angiogenesis has been shown to be highly tissue- and context-specific and as a result can yield either pro- or antiangiogenic effects. For these reasons, there is considerable interest in determining the molecular underpinnings of Treg-mediated modulation of angiogenesis in different disease states. The present review summarizes the role of Tregs in angiogenesis and mechanisms by which Tregs regulate angiogenesis and discusses how these mechanisms differ in homeostatic and pathological settings.

Indexed as

AnimalsHumansInflammationModels, AnimalNeoplasmsNeovascularization, PathologicNeovascularization, PhysiologicSignal TransductionT-Lymphocytes, RegulatoryVascular Endothelial Growth Factor AVascular Endothelial Growth Factor A

Identifiers

PMID33168598
PMCPMC7664842
OpenAlexW3099132326

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.